Chemotherapy for ovarian mucinous cystadenocarcinoma during pregnancy: A case report

European Journal of Gynaecological Oncology

Volumn 25, Issue 5, 2004, Pages 635-636

  Huang, H P ^a   Fang, C N ^a   Kan, Y Y ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chemotherapy; Ovarian malignancy; Pregnancy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE;

ADULT; ARTICLE; BREECH PRESENTATION; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CESAREAN SECTION; CYSTADENOCARCINOMA; EMERGENCY SURGERY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LAPAROTOMY; OVARIAN MUCINOUS CYSTADENOCARCINOMA; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; SECOND TRIMESTER PREGNANCY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CESAREAN SECTION; CISPLATIN; CYCLOPHOSPHAMIDE; CYSTADENOCARCINOMA, MUCINOUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; OVARIAN NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY TRIMESTER, SECOND;

EID: 4644247675     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hoffman M., Cavanagh D., Walter T., Ionata E., Ruffolo E.: "Adenocarcinoma of the endometrium with pregnancy". Gynecol. Oncol., 1989, 32, 82.
2. Doll D.C., Ringenberg S., Yarbo J.W.: "Antineoplastic agents and pregnancy". Semin. Oncol., 1989, 16, 337.
3. Ebert U., Loffler H., Kirch W.: "Cytotoxic therapy and pregnancy". Pharmacol. Ther., 1997, 74 (2), 207.
4. Raffles A., Williams J., Costeloe K., Clark P.: "Transplacental effects of maternal cancer chemotherapy: Case report". Br. J. Obstet. Gynaecol., 1989, 96, 1099.
5. Kai S., Kohmura H., Hiraiwa E. et al.: "Reproductive and developmental toxicity studies of paclitaxel. II. Intravenous administration to rats during the fetal organogenesis". J. Toxicol. Sci., 1994, 19S, 69.
6. Sood A.K., Shahin M.S., Sorosky J.I.: "Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy". Gynecol. Oncology, 2001, 83 (3), 599.